Market Tracker

10/20 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.21
Delayed Data
As of Oct 20
 -0.04 / -3.20%
Today’s Change
0.79
Today|||52-Week Range
3.38
-46.22%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.25
Today’s open1.23
Day’s range1.16 - 1.28
Volume455,545
Average volume (3 months)822,746
Market cap$125.6M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+40.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
STDYSteadymed Ltd-0.02-0.80%
GEMPGemphire Therapeutic...-0.16-1.69%
GLMDGalmed Pharmaceutica...-0.01-0.13%
GTXIGTX Inc+0.10+1.28%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts